Share your insights

Help us by sharing what content you've recieved in your exams


Pancytopenia

Background knowledge 🧠

Definition

  • Pancytopenia refers to a reduction in all three blood cell lines: red blood cells (anaemia), white blood cells (leukopenia), and platelets (thrombocytopenia).
  • Represents a broad spectrum of underlying pathologies, ranging from benign to life-threatening.

Epidemiology

  • Pancytopenia is relatively uncommon but can be seen across all age groups.
  • Incidence varies based on the underlying cause (e.g., more common in aplastic anaemia, leukaemia).
  • Geographical variations exist; certain aetiologies are more prevalent in specific regions.

Aetiology and Pathophysiology

  • Bone marrow failure (e.g., aplastic anaemia, myelodysplastic syndromes).
  • Infiltration of bone marrow by malignancies (e.g., leukaemia, lymphoma, metastatic cancer).
  • Infectious causes (e.g., HIV, hepatitis, tuberculosis).
  • Medications and toxins (e.g., chemotherapy, benzene exposure).
  • Autoimmune disorders (e.g., systemic lupus erythematosus).
  • Hypersplenism causing peripheral destruction.

Types

  • Primary (e.g., inherited bone marrow failure syndromes).
  • Secondary (e.g., acquired conditions like aplastic anaemia, bone marrow infiltration).
  • Transient (e.g., due to temporary bone marrow suppression from infection or drugs).

Clinical Features 🌑️

Symptoms

  • Fatigue, pallor, and weakness due to anaemia.
  • Frequent infections, fevers due to leukopenia.
  • Easy bruising, petechiae, or bleeding tendencies due to thrombocytopenia.
  • Dyspnoea, particularly on exertion, in severe cases.
  • Symptoms of underlying conditions (e.g., night sweats, weight loss in malignancies).

Signs

  • Pallor, particularly of the conjunctiva and skin.
  • Petechiae, purpura, or ecchymoses.
  • Hepatosplenomegaly in cases with infiltrative or hypersplenic causes.
  • Lymphadenopathy in malignancies or infections.
  • Fever in cases with concurrent infection.

Investigations πŸ§ͺ

Tests

  • Full blood count (FBC) showing reductionsΒ in haemoglobin, white cells, and platelets.
  • Peripheral blood smear for morphological abnormalities.
  • Bone marrow biopsy to assess cellularity, presence of malignancy, or fibrosis.
  • Serological tests for infections (e.g., HIV, hepatitis).
  • Imaging studies (e.g., CT scan) if malignancy or splenic involvement is suspected.
  • Flow cytometry for assessment of haematological malignancies.

Management πŸ₯Ό

Management

  • Treatment of underlying cause (e.g., immunosuppression in autoimmune conditions, chemotherapy for malignancies).
  • Supportive care (e.g., transfusions of red cells or platelets).
  • Antibiotic prophylaxis or treatment for infections.
  • Growth factor support (e.g., G-CSF for neutropenia).
  • Bone marrow or stem cell transplantation in suitable cases.
  • Monitoring for complications like bleeding or severe infections.

Complications

  • Severe infections due to prolonged neutropenia.
  • Severe bleeding episodes, particularly intracranial or gastrointestinal.
  • Iron overload from repeated transfusions.
  • Transformation to acute leukaemia in some haematological disorders.
  • Graft-versus-host disease (GVHD) post-transplant.

Prognosis

  • Highly variable depending on the underlying cause and response to treatment.
  • Poor prognosis in untreated or refractory cases, particularly malignancies.
  • Better outcomes with early diagnosis and targeted therapy.
  • Long-term survival possible in cases managed with bone marrow transplantation.

Key Points

  • Pancytopenia is a clinical finding, not a diagnosis, requiring thorough investigation.
  • Management depends on identifying and treating the underlying cause.
  • Early recognition and intervention are crucial for improving outcomes.
  • Requires a multidisciplinary approach including haematology, oncology, and infectious disease specialists.
  • Patient monitoring and supportive care are essential to managing complications.

No comments yet πŸ˜‰

Leave a Reply

Child health